Greg Miller, PhDÂ
Dr. Miller is an internationally recognized leader in advancing the standardization and harmonization of clinical laboratory assays, particularly in collaboration with the nephrology community to improve the accuracy and consistency of kidney disease-related biomarker measurement.Â
Dr. Miller led in the global standardization of serum creatinine assays, serving with multiple working groups and committees in the fields of nephrology and kidney disease. He was a member of the National Kidney Foundation–American Society of Nephrology task force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases, which developed landmark recommendations to eliminate race-based correction from glomerular filtration rate (GFR) estimation and recommended immediate implementation of the 2021 race-free CKD‑EPI GFR estimating equations.Â
Dr. Miller has provided 26 years of dedicated service to CAP committees, including the Accuracy-Based Programs and Chemistry Committees. He was a major contributor and author of the CAP public statement on race-based estimated GFR, and his expertise has been central to the development and implementation of accuracy-based PT programs that have strengthened laboratory quality and reinforced the CAP’s leadership in quality assurance.Â
Recognition of Dr. Miller’s contributions has included being named to the National Kidney Foundation’s 75 Kidney Heroes list (2025) and receiving the CLSI’s Russell J. Eilers Memorial Award (2018), the Robert Schaffer Award for Outstanding Achievements in the Development of Standards for Laboratory Medicine from the IFCC (2014), and the Outstanding Lifetime Achievement Award in Clinical Chemistry and Laboratory Medicine from the AACC (2007). Â
Dr. Miller has remained deeply committed to advancing standardization in laboratory medicine and improving clinical care for patients through excellence in laboratory measurement.Â
Dr. Miller is a professor of pathology at Virginia Commonwealth University Health System in Richmond, Virginia. Â